<DOC>
	<DOC>NCT00668200</DOC>
	<brief_summary>This study will evaluate the impact of investigator and patient education and educational materials to foster calcium and vitamin D supplementation to mitigate the potential for hypocalcemia post Reclast速 administration in patients with Paget's disease of bone.</brief_summary>
	<brief_title>Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast速</brief_title>
	<detailed_description />
	<mesh_term>Hypocalcemia</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Osteitis Deformans</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Written informed consent As per currently approved Reclast速 Package Insert: As per currently approved Reclast速 Package Insert:</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Paget's</keyword>
	<keyword>hypocalcemia</keyword>
	<keyword>zoledronic acid</keyword>
	<keyword>serum calcium</keyword>
</DOC>